Xiao Juan

Specializzazione: Pediatric hematologist/oncologist
19 anni di esperienza
Studio medico: Cina, Pechino, Beijing Jingdu Children’s Hospital
As a specialist at the clinic, Dr. Xiao Juan is Chief Physician and Ward Director of Ward 9 in the Hematology Oncology Center at Beijing Jingdu Children’s Hospital. Her profile describes nearly 20 years of clinical experience focused on hematopoietic stem cell transplantation (HSCT) and cellular immunotherapy for refractory childhood blood diseases. She won an Excellent Paper Award at the 28th National Academic Conference on Pediatrics of the Chinese Medical Association for work on refractory acute B lymphoblastic leukemia in children. Her clinical scope includes HSCT and cellular immunotherapy, and she is associated with Ward 9 as a core HSCT and refractory blood disease treatment unit.
Dr. Xiao Juan is a specialist at the clinic and Chief Physician/Ward Director of Ward 9 in the Hematology Oncology Center at Beijing Jingdu Children’s Hospital. With nearly 20 years of clinical experience, she focuses on HSCT and cellular immunotherapy for refractory childhood blood diseases, including refractory acute B lymphoblastic leukemia. Her differentiator includes academic recognition—an Excellent Paper Award at the 28th National Academic Conference on Pediatrics of the Chinese Medical Association for refractory acute B lymphoblastic leukemia in children.

Com'è andata la tua esperienza?

1 di 3

Le informazioni su questo medico sono complete e chiare

Totalmente in disaccordo

Totalmente d'accordo

Formazione accademica

Dr. Xiao Juan’s clinical and academic profile is centered on HSCT and cellular immunotherapy for children with refractory blood cancers. As a specialist at the clinic, she is Chief Physician and Ward Director of Ward 9 in the Hematology Oncology Center at Beijing Jingdu Children’s Hospital. Her profile describes nearly 20 years of clinical experience and positions her as an authoritative expert in hematopoietic stem cell transplantation (HSCT) and the treatment of refractory childhood blood diseases. She also has an academic track record including an Excellent Paper Award at the 28th National Academic Conference on Pediatrics of the Chinese Medical Association for work on refractory acute B lymphoblastic leukemia in children.

Education

Tongji Medical College, Huazhong University of Science and Technology — MD (Doctor of Medicine) (graduation year not stated).
Wuhan Union Hospital — postgraduate clinical training (years not stated).
Beijing Daopei Hospital — postgraduate clinical training (years not stated).

Work experience

Chief Physician and Ward Director, Ward 9, Hematology Oncology Center — Beijing Jingdu Children’s Hospital.

Clinical focus and techniques

Dr. Xiao Juan’s practice focuses on advanced hematology therapies for difficult pediatric cases.

Hematopoietic stem cell transplantation (HSCT).
Cellular immunotherapy.
HSCT and cellular immunotherapy for refractory childhood blood diseases.

Courses and advanced training

28th National Academic Conference on Pediatrics of the Chinese Medical Association — Excellent Paper Award (topic: refractory acute B lymphoblastic leukemia in children).

Awards and recognition

Excellent Paper Award — 28th National Academic Conference on Pediatrics of the Chinese Medical Association (year not stated).

Professional societies and certifications

No specific society memberships or certifications are listed in the provided materials.

For international families, the clinic’s Ward 9 pathway supports HSCT evaluation and cellular immunotherapy planning. Dr. Xiao Juan’s clinical focus includes refractory acute B lymphoblastic leukemia and other refractory childhood blood diseases where transplant-level treatment may be considered.